The courts seem to be saying: we don't care about your techniques, we protect the drug patent. I always assumed that the patent held by MNTA was some very specialized Intellectual Property that would be protected. I see now in the Classen case a patent was issued for a dose time schedule! To me that may be useful science but really nothing. Perhaps the courts see MNTA's lab technique as useful science but really nothing. Now if MNTA had bio-engineered a bacteria to produce Generic Lovenox, or a machine that created the drug; those might be enforceable patents.
Market Data 
Markets 
AI
